Advanced Search

 

Study ID Status Title Patient Level Data
S7121359 Completed Evaluation of the Nicotine Mini Lozenge in Relief of Provoked Acute Craving
SALMD/AH90/J85 Completed A phase IV, multi-centre, double-blind, double-dummy, parallel group study to determine whether adult asthmatic patients, currently symptomatic on 400mcg daily inhaled corticosteroid therapy, are better maintained by an increase in corticosteroid dose to 1000mcg daily beclomethasone dipropionate ...
SALMP/AH91/D89 Completed A phase III, multi-centre, double-blind, placebo controlled, parallel group study assessing the efficacy and safety of inhaled salmeterol xinafoate (Serevent™) 50 micrograms BD via the Diskhaler™ when added to the existing treatment of moderate to severe asthmatic children.
SALMP/AH93/J119 Completed A phase IV, multi-centre, double-blind, randomised, parallel group study in general practice to compare the efficacy and tolerability of inhaled salmeterol xinafoate 50 micrograms bd with placebo, both administered via the Diskhaler, in the treatment of episodic asthma induced by upper respirato ...
SAM 106538 Completed Asthma control assessment via ACT and DRC in Asthmatics treated with Seretide (50/250) over 12 weeks
SAM101667 Completed A multicentre, randomised, double-blind, parallel group study to compare the efficacy and safety of Salmeterol/Fluticasone propionate combination product (Seretide®) 50/100 mcg with Fluticasone propionate (Flixotide® ) 200 mcg, both delivered twice daily via the DISKUS inhaler, in the treatment of children aged 6-12 years with symptomatic asthma
SAM103848 Completed Randomised, double-blind, double-dummy, parallel-group, comparative study of salmeterol/FP 50/100mcg bd inhalation powder via Diskus with oral Montelukast (5mg QD) chewable tablets in Children 6-14 years
SAM104926 Completed A multicentre, randomised, double-blind, double dummy, parallel group study to compare the salmeterol/fluticasone propionate combination (SeretideTM) at a dose of 50/100µg twice daily and fluticasone propionate (FlixotideTM) at a dose of 200µg twice daily, both delivered via a dry powder inhaler (DiskusTM) for 12 weeks in asthma in children aged 4-11 years not controlled by inhaled corticosteroids alone at medium dose Study Listed on ClinicalStudyDataRequest.com
SAM108037 Terminated Seretide 100 DK vs Flixotide 100 DK in IMT in moderate asthma in adults on static lung volumes (mechanistic study)
SAM30001 Completed Compliance in asthma and COPD treatment.
SAM30002 Completed A randomised, multi-centre, double blind, double-dummy, parallel-group comparison of Seretide RPID (50/100g strength) bd with budesonide BADPI 400g bd in steroid experienced adolescents and adults with reversible airways obstruction.
SAM30003 Completed A multicentre, randomised , open-label, parallel group comparison of Seretide Accuhaler TM bd with salmeterol 50mg twice daily via one Accuhaler and either fluticasone propionate 250mg or 500mg twice daily via a separate Accuhaler in adults with reversible airways disease.
SAM30007 Completed A multicentre, randomised, double-blind, controlled, parallel-group, comparative investigation of the corticosteroid-saving potential of the combination therapy fluticasone propionate and salmeterol compared with fluticasone propionate alone, given to adult asthmatic subjects, when reducing…
SAM30008 Completed A multi-centre, randomized, open-label, parallel-group, comparison study of the salmeterol/fluticasone propionate combination product via one Diskus/Accuhaler inhaler with salmeterol via one Diskus/Accuhaler inhaler and fluticasone propionate via another Diskus/Accuhaler inhaler in adults with ...
SAM30010 Completed A Randomized, Single-centre, Double-blind, Parallel-group Comparison of Seretide Accuhaler (50/250 µg Strength) bd with Fluticasone Accuhaler 250 µg bd in Subjects with Reversible Airways Obstruction
SAM30012 Completed An open study to assess the efficacy and safety of Seretide Diskus (salmeterol/fluticasone propionate 50/500mg strength) bd in subjects with reversible airways obstruction
SAM30013 Completed A 12 week, randomized, double-blind, parallel group study to compare the efficacy and safety of salmeterol/fluticasone propionate/GR106642X (25/50 µg x 2 inhalations) bid with fluticasone propionate (125 µg x 2 inhalations) bid in adolescent and adult patients with mild to moderate asthma.
SAM30020 Completed Efficacy and tolerability of the salmeterol/fluticasone 50/100 mcg combination Diskus, inhaled once daily in the evening, in comparison to the p.r.n. inhalation from the reproterol/sodium cromoglycate 0.5/ 1 mg combination MDI, as initial therapy for patients with mild asthma – a multicentre, ra ...
SAM30021 Completed A multi-centre, randomised, open-label, parallel group clinical trial to assess the efficacy and safety of Salmeterol/Fluticasone Propionate combination product (2x 25/125mg/actuation, bd) via a hydrofluoroalkane metered-doseinhaler compared…
SAM30022 Completed A phase IV, multi-centre, double-blind, double-dummy, parallel group, randomised study comparing Seretide (25/50 2 puffs bd) via the Evohaler (MDI-HFA) with Beclometasone dipropionate (200mcg 2 puffs bd) via the MDI-CFC in adolescents and adults experiencing moderate symptoms of reversible airwa ...
SAM3802 Completed An observational study to assess the health related quality of life impact of treating poorly controlled asthmatic children with Seretide 50/100mcg
SAM40004 Completed A multi-centre, randomised, double-blind, placebo-controlled parallel group study to compare the effect on airway inflammation and remodeling of treatment with salmeterol/fluticasone propionate combination product (50/100mg strength) bd via the Accuhaler inhaler, or fluticasone propionate…
SAM40008 Completed A Multicentre, Randomised, Double-Blind, Parallel Group Comparison of the Efficacy of SERETIDE* bd and Fluticasone Propionate bd (Both Via DISKUS*/ACCUHALER*, Inhaler) when Tapering the Inhaled Corticosteroid Dose in Asthmatic Adults Study Listed on ClinicalStudyDataRequest.com
SAM40010 Completed A randomised, double blind, double-dummy, parallel-group, twelve week comparison of salmeterol/fluticasone propionate (FP) DISKUS/ACCUHALER 50/100mcg bd. with budesonide 200mcg bd. plus formoterol 4.5mcg bd. (both via breath-actuated dry powder inhaler [BADPI]) in Adult and Adolescent Asthmatics.
SAM40012 Completed A multicentre, randomised, double-blind, double-dummy, parallel group comparison of three treatments : 1) salmeterol/fluticasone propionate (SFC) 50/100mcg strength) bd via DISKUS/ACCUHALER inhaler, 2) fluticasone propionate 200mcg bd via DISKUS/ACCUHALER inhaler, 3) fluticasone propionate 100mcg bd via DISKUS/ACCUHALER inhaler in children aged 4- 11 years with asthma Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.